Bartosz Wojciech Bichalski

Mr. Bartosz Wojciech Bichalski

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BBBartosz Wojciech Bichalski
Bartosz Wojciech Bichalski
MBMagda Grażyna Bichalska-Lach
Magda Grażyna Bichalska-Lach
DWDariusz Waniczek
Dariusz Waniczek
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy worldwide and remains a major challenge in contemporary oncology, where early detection is critical for improving treatment outcomes and survival. Despite significant progress in diagnostics and therapy, the epidemiology, risk factors, and molecular mechanisms driving CRC development continue to be intensively investigated. This paper provides an overview of current trends in CRC diagnosis and management, with particular emphasis on advances in molecular medicine and biological sciences. Screening recommendations in Poland are discussed, comparing invasive methods—such as colonoscopy, sigmoidoscopy, and CT colonography—with non-invasive stool-based tests (FOBT, FIT, sDNA-FIT), and evaluating their sensitivity, specificity, and impact on mortality reduction. Key tumor markers with diagnostic, prognostic, and predictive value, including CEA, CA19-9, mSEPT9, ctDNA, TPS, TAG-72, CTCs, and circulating microRNAs, as well as p53 and PTEN proteins, are reviewed in the context of their clinical utility in early detection, disease monitoring, and treatment response assessment. The analysis also highlights the epidemiological situation in Poland and underscores the growing importance of integrating molecular biomarkers with traditional diagnostic methods, which may ultimately support the development of more precise and individualized clinical management strategies in the future.

10 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MNMichał Nycz
Michał Nycz
DWDariusz Waniczek
Dariusz Waniczek
MMMalgorzata Muc-Wierzgon
Malgorzata Muc-Wierzgon
KSKarolina Snopek-Miśta
Karolina Snopek-Miśta
MKMariusz Kryj
Mariusz Kryj
ZLZbigniew Lorenc
Zbigniew Lorenc
Background/Objectives: Colorectal cancer (CRC) is one of the most common malignancies worldwide, with systemic inflammation increasingly recognised as a determinant of disease progression. This study aimed to establish a taxonomy-based classification of patients with newly diagnosed primary CRC using systemic inflammatory, haematological, and anthropometric markers, and to evaluate its association with tumour stage. Methods: A total of 229 patients (111 women, 118 men) undergoing surgery for primary CRC were included. Blood samples were analysed for haemoglobin, leukocytes, neutrophils, lymphocytes, platelets, C-reactive protein (CRP), and carcinoembryonic antigen (CEA). Anthropometric data were collected. Taxonomic clustering and ordinal logistic regression were used to explore associations with TNM and Astler–Coller classifications. Results: Men had higher neutrophil and leukocyte counts, elevated CEA concentrations (132.8 vs. 81.3 ng/mL), and higher NLR values (4.74 vs. 4.23) compared with women. Logistic regression confirmed that platelet count (OR 1.003; p = 0.004), PLR (OR 1.003; p = 0.003), and CEA (OR 1.03; p < 0.001) were positively associated with advanced TNM stage, while haemoglobin was inversely correlated (OR 0.88; p = 0.045). Among 84 clustering models, two taxonomies were the most clinically informative: Taxonomy I (BMI, neutrophils, platelets) and Taxonomy II (age, lymphocytes, platelets), both significantly associated with T, N, M, overall TNM stage, and Astler–Coller grade. Taxonomy I identified three patient groups. Type 3 represented the poorest phenotype, characterised by low BMI and haemoglobin, high platelets, elevated CEA and PLR, and predominance of TNM IIIC tumours, consistent with a cachectic–inflammatory profile. Type 1 displayed higher BMI, lower inflammation, and earlier-stage disease. Type 2 was characterized by elevated neutrophils and leukocytes. Taxonomy II distinguished four groups, with Type 2 demonstrating the most favourable profile (high haemoglobin and lymphocytes, low NLR and PLR, early TNM stage). Conclusions: Systemic inflammatory markers, haemoglobin, platelets, and CEA strongly predict CRC advancement. The proposed taxonomy provides clinically meaningful stratification of CRC patients and may support personalised risk assessment. This accessible approach may facilitate early identification of high-risk individuals, although validation in prospective studies is required.

24 August 2023 in Annales Academiae Medicae Silesiensis
Verified
Journal Article
Open access
JFJakub Fick
Jakub Fick
MBMagda Grażyna Bichalska-Lach
Magda Grażyna Bichalska-Lach
BBBartosz Wojciech Bichalski
Bartosz Wojciech Bichalski
MRMarek Rudzki
Marek Rudzki
DWDariusz Waniczek
Dariusz Waniczek
Corynebacterium diphtheriae (C. diphtheriae) jest pierwotnym patogenem wywołującym błonicę, która zasadniczo występuje w dwóch postaciach: nosowo-gardłowej i skórnej. W związku z powszechnymi szczepieniami przeciwko błonicy, krztuścowi i tężcowi (diphtheria, pertussis and tetanus – DPT) częstość występowania błonicy na świecie znacząco zmalała, na niektórych obszarach zanikając niemal całkowicie. W dzisiejszych czasach ponownie obserwujemy przypadki błonicy, zwłaszcza postaci skórnej, nawet w krajach z wysokim wskaźnikiem wyszczepienia, w związku z nasilającą się migracją z krajów o niższym odsetku zaszczepionych obywateli. Prezentujemy studium przypadku ukraińskiego imigranta ze zdiagnozowaną błonicą skóry, by zwiększyć świadomość środowiska medycznego o tej powracającej chorobie, jej postaci skórnej oraz związanych z tym nowych wyzwaniach. To pierwszy zaraportowany przypadek zakażenia C. diphtheriae w Polsce od 2005 r. Przeanalizowano najnowsze artykuły dostępne w bazach PubMed i Google Scholar, używając jako kryterium następujących słów kluczowych: „błonica przypadek”, „błonica opis przypadku”, „błonica skóry”. Wybrano artykuły o najwyższej korelacji z ponad 1700 wyników wyszukiwania. Opis przypadku i analiza publikacji naukowych na temat błonicy skóry pokazują znaczenie tej postaci choroby w nowej, poszczepiennej erze. Twierdzimy, że szczepienia, stosowanie ochrony osobistej podczas kontaktu z pacjentem oraz świadomość środowiska medycznego dotycząca możliwych zagrożeń stają się jeszcze bardziej istotne.

2 October 2026 in Langenbeck's Archives of Surgery
Verified
Journal Article
Open access
PDF file
BMBartosz Molasy
Bartosz Molasy
MPMagdalena Pawelec
Magdalena Pawelec
DGDamian GręBosz
Damian GręBosz
MKMateusz Kubicki
Mateusz Kubicki
MBMagdalena Babińska
Magdalena Babińska
KMKryspin Mitura
Kryspin Mitura
Purpose Emergency abdominal surgery carries a high risk of postoperative morbidity, yet prospective multicentre data on real-world abdominal wall closure practices remain limited. This interim analysis of the PROPHECY study aimed primarily to characterise current abdominal wall management and variation in practice across centres, and secondarily to describe early postoperative outcomes. Methods This prespecified interim analysis included adult patients undergoing emergency abdominal surgery in a prospective multicentre cohort across Poland (June–December 2025). Patients were grouped by operative access (laparotomy, laparoscopy, conversion). Closure practices and early outcomes, including surgical-site infection (SSI), fascial dehiscence, major postoperative morbidity (Clavien–Dindo ≥ III), in-hospital mortality, and length of stay, were assessed. Multivariable mixed-effects models with a random intercept for centre were used where applicable. Results Of 850 screened patients, 828 from 24 centres were included; 273 (33.0%) underwent laparotomy, 500 (60.4%) laparoscopy, and 55 (6.6%) conversion. Substantial variation between centres was observed in abdominal wall management, particularly in the use of short-stitch closure, subcutaneous drainage, and prophylactic negative-pressure wound therapy, whereas fascial closure of larger camera ports was nearly universal. Prophylactic mesh reinforcement was uncommon. SSI occurred in 9.3%, fascial dehiscence in 2.4%, major morbidity in 11.2%, and in-hospital mortality in 3.0%. Differences in early outcomes between operative approaches persisted in adjusted analyses but should be interpreted in the context of substantial differences in case-mix and potential residual confounding. Conclusion Emergency abdominal surgery is characterised by substantial variation in abdominal wall management across centres despite existing recommendations. This prospective real-world benchmark identifies areas of inconsistent practice and provides the clinical context for the planned 12-month assessment of incisional, port-site, and parastomal hernia outcomes in the PROPHECY cohort.

26 June 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
BBBartosz Wojciech Bichalski
Bartosz Wojciech Bichalski
MBMagda Grażyna Bichalska-Lach
Magda Grażyna Bichalska-Lach
MNMichał Nycz
Michał Nycz
MKMariusz Kryj
Mariusz Kryj
MSMiroslaw Snietura
Miroslaw Snietura
DWDariusz Waniczek
Dariusz Waniczek
Background: Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide. While established molecular biomarkers such as microsatellite instability (MSI), KRAS, and BRAF are routinely used in clinical practice, the prognostic relevance of tumor suppressor proteins p53 and PTEN remains incompletely defined, particularly when assessed using immunohistochemistry. Objective: The primary aim of this study was to evaluate the prognostic significance of p53 expression and PTEN deficiency in colorectal adenocarcinoma. Secondary aims included assessment of their association with clinicopathological characteristics. Methods: This retrospective cohort study included 103 consecutive patients who underwent surgical resection for colorectal adenocarcinoma. Immunohistochemical analysis of formalin-fixed paraffin-embedded (FFPE) tumor samples was performed to assess aberrant p53 expression and PTEN deficiency. Associations with clinicopathological variables were evaluated, and overall survival was analyzed using Kaplan–Meier curves and Cox proportional hazards regression models. Results: Aberrant p53 expression and PTEN deficiency were both associated with shorter overall survival in univariate analyses. Patients with concurrent aberrant p53 expression and PTEN deficiency demonstrated the poorest survival outcomes. However, in multivariate Cox regression analysis, only nodal status and age remained independent predictors of overall survival, while p53 and PTEN did not retain independent prognostic significance after adjustment for clinicopathological variables. Conclusions: Aberrant p53 expression and PTEN deficiency are associated with reduced overall survival in colorectal cancer; however, their prognostic impact appears secondary to established clinicopathological factors. The combined presence of these alterations may identify a biologically aggressive subgroup of patients with particularly unfavorable outcomes, although this observation should be considered exploratory. Further validation in larger, independent cohorts is required.